Literature DB >> 21420302

Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability.

Hanae Benelkebir1, Sabrina Marie, Annette L Hayden, Jason Lyle, Paul M Loadman, Simon J Crabb, Graham Packham, A Ganesan.   

Abstract

The total synthesis of largazole and four analogues is reported. All analogues were nanomolar HDAC inhibitors. The antiproliferative activity is driven by lipophilicity and cell permeability. In murine liver homogenates, largazole is rapidly metabolized (half-life ≤5 min) to the thiol which has a half-life of 51 min.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420302     DOI: 10.1016/j.bmc.2011.02.024

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  16 in total

Review 1.  An overview of naturally occurring histone deacetylase inhibitors.

Authors:  Bumki Kim; Jiyong Hong
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

2.  Biological evaluation of new largazole analogues: alteration of macrocyclic scaffold with click chemistry.

Authors:  Xianlin Li; Zhenchao Tu; Hua Li; Chunping Liu; Zheng Li; Qiao Sun; Yiwu Yao; Jinsong Liu; Sheng Jiang
Journal:  ACS Med Chem Lett       Date:  2012-12-05       Impact factor: 4.345

3.  Isoform-selective HDAC1/6/8 inhibitors with an imidazo-ketopiperazine cap containing stereochemical diversity.

Authors:  Bertrand Lecointre; Remy Narozny; Maria Teresa Borrello; Johanna Senger; Alokta Chakrabarti; Manfred Jung; Martin Marek; Christophe Romier; Jelena Melesina; Wolfgang Sippl; Laurent Bischoff; A Ganesan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

4.  Structural basis of the antiproliferative activity of largazole, a depsipeptide inhibitor of the histone deacetylases.

Authors:  Kathryn E Cole; Daniel P Dowling; Matthew A Boone; Andrew J Phillips; David W Christianson
Journal:  J Am Chem Soc       Date:  2011-07-26       Impact factor: 15.419

5.  Synthesis and Antiproliferative Activity of Nitric Oxide-Donor Largazole Prodrugs.

Authors:  Matteo Borgini; Claudio Zamperini; Federica Poggialini; Luca Ferrante; Vincenzo Summa; Maurizio Botta; Romano Di Fabio
Journal:  ACS Med Chem Lett       Date:  2020-02-07       Impact factor: 4.345

Review 6.  Largazole: from discovery to broad-spectrum therapy.

Authors:  Jiyong Hong; Hendrik Luesch
Journal:  Nat Prod Rep       Date:  2012-02-14       Impact factor: 13.423

7.  Largazole Analogues Embodying Radical Changes in the Depsipeptide Ring: Development of a More Selective and Highly Potent Analogue.

Authors:  Jehad Almaliti; Ayad A Al-Hamashi; Ahmed T Negmeldin; Christin L Hanigan; Lalith Perera; Mary Kay H Pflum; Robert A Casero; L M Viranga Tillekeratne
Journal:  J Med Chem       Date:  2016-11-21       Impact factor: 7.446

8.  Synthesis and biological evaluation of largazole analogues with modified surface recognition cap groups.

Authors:  Pravin Bhansali; Christin L Hanigan; Lalith Perera; Robert A Casero; L M Viranga Tillekeratne
Journal:  Eur J Med Chem       Date:  2014-09-06       Impact factor: 6.514

9.  Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors.

Authors:  Fei Chen; Hui Chai; Ming-Bo Su; Yang-Ming Zhang; Jia Li; Xin Xie; Fa-Jun Nan
Journal:  ACS Med Chem Lett       Date:  2014-04-04       Impact factor: 4.345

10.  Evaluation of class I HDAC isoform selectivity of largazole analogues.

Authors:  Bumki Kim; Heekwang Park; Lilibeth A Salvador; Patrick E Serrano; Jason C Kwan; Sabrina L Zeller; Qi-Yin Chen; Soyoung Ryu; Yanxia Liu; Seongrim Byeon; Hendrik Luesch; Jiyong Hong
Journal:  Bioorg Med Chem Lett       Date:  2014-07-09       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.